The quick commerce major has made the service available in select places including Bengaluru, Mumbai and Hyderabad. Users can ...

Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the decline of its Covid business.

This strategic acquisition, which entails acquiring the perpetual licence of Velvette, aligns with Reliance's ongoing ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

Otsuka has dumped a clutch of clinical cancer candidates on Valentine's day. | Otsuka has broken up with a clutch of clinical ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Top start-up accelerators for tech companies in 2025Issued by Emerging SoftwareJohannesburg, 14 Feb 2025Visit our press officeStart-up accelerators are intensive, short-term programmes designed to ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...